Publicado May 19, 2022



PLUMX
Almetrics
 
Dimensions
 

Google Scholar
 
Search GoogleScholar
Descargas


Marcela Arrivillaga

Sheila Andrea Gómez

Héctor Fabio Mueses

Beatriz Alvarado

Ernesto Martínez Buitrago

Pilar Camargo-Plazas

Lina Rocio Hurtado

Maria Camila Bolívar

Ximena Galindo

Julián Torres

Jorge Luis Cajas-Martínez

##plugins.themes.bootstrap3.article.details##

Resumen

Este artículo describe facilitadores y recomendaciones de proveedores de salud de clínicas de VIH para la implementación de PPrE en Colombia. Se realizó un estudio cualitativo con entrevistas semiestructuradas a 20 proveedores de salud de 9 clínicas. Se utilizó el “Marco Consolidado para avanzar en la Ciencia de la Implementación” para guiar el análisis de contenido de los hallazgos. Los resultados fueron: Características de la intervención: los proveedores reconocen PPrE como una terapia innovadora, de demostrada efectividad; recomiendan que debe implementarse por normativa nacional del Ministerio de Salud y Protección Social, con compra centralizada de medicamentos y adaptaciones a las diversidades regionales. Para ensamblar la PPrE en las clínicas, recomiendan articularla a programas preventivos de salud sexual, orientados por equipos interdisciplinarios capacitados. Ambiente externo: se recomendó fortalecer el trabajo en red con las secretarias de salud, Profamilia y organizaciones LGTBI; cambiar condiciones de contratación con las Entidades Promotoras de Salud para incluir PPrE dirigido a parejas de pacientes con VIH, y financiar con recursos públicos a personas que no la pueden pagar.  Ambiente interno: clima y disponibilidad de implementación percibidos como favorables para la adopción de PPrE; para reducir tensiones organizacionales por el cambio recomiendan expandir los planes de capacitación. Proceso de implementación: se recomienda el diseño de planes nacionales, locales e institucionales, así como la atracción de líderes clave internos y externos. Se concluye que los proveedores de salud de los clínicas para VIH en Colombia perciben un ambiente favorable para la adopción de PPrE en el país.

Keywords

Implementation Science, Pre-Exposure Prophylaxis, AIDS Serodiagnosis, Preventive Health ServicesCiencias de la implementaci´ón, Profilaxis Pre-Exposición, Servicios Preventivos de Salud, Serodiagnóstico del SIDACiência da Implementação, Profilaxia Pré-Exposição, Sorodiagnóstico da AIDS, Serviços Preventivos de Saúde

References
World Health Organization. Guideline on When To Start Antiretroviral Therapy and on Pre-Exposure Prophylaxis for HIV. 2015.
2. Anderson PL, Glidden D V., Liu A, Buchbinder S, Lama JR, Guanira JV, et al. Emtricitabine-Tenofovir Concentrations and Pre-Exposure Prophylaxis Efficacy in Men Who Have Sex with Men. Sci Transl Med [Internet]. 2012 Sep 12 [cited 2020 Jun 24];4(151):151ra125-151ra125. Available from: https://stm.sciencemag.org/lookup/doi/10.1126/scitranslmed.3004006
3. Fonner VA, Dalglish SL, Kennedy CE, Baggaley R, O’Reilly KR, Koechlin FM, et al. Effectiveness and safety of oral HIV preexposure prophylaxis for all populations. AIDS [Internet]. 2016 Jul 31 [cited 2021 Jan 25];30(12):1973–83. Available from: /pmc/articles/PMC4949005/?report=abstract
4. Ravasi G, Grinsztejn B, Baruch R, Guanira JV, Luque R, Cáceres CF, et al. Towards a fair consideration of PrEP as part of combination HIV prevention in Latin America [Internet]. Vol. 19, Journal of the International AIDS Society. International AIDS Society; 2016 [cited 2021 Jan 14]. p. 21113. Available from: http://doi.wiley.com/10.7448/IAS.19.7.21113
5. Pan American Health Organization and Joint United Nations Programme on HIV/AIDS (PAHO/UNAIDS). HIV prevention Spotlight: : An Analysis from the Perspective of the Health Sector in Latin America and the Caribbean [Internet]. Vol. 01, PAHO, UNAIDS. PAHO; 2017 [cited 2021 Jan 25]. 1–7 p. Available from: https://iris.paho.org/handle/10665.2/34381
6. Cáceres CF. HIV among gay and other men who have sex with men in Latin America and the Caribbean: A hidden epidemic? Vol. 16, AIDS. 2002.
7. UNAIDS. AIDSinfo | UNAIDS [Internet]. [cited 2021 Jan 25]. Available from: http://aidsinfo.unaids.org/
8. AVERT. HIV and AIDS in Latin America regional overview [Internet]. 2015 [cited 2021 Jan 25]. Available from: https://www.avert.org/professionals/hiv-around-world/latin-america/overview#footnote65_jpc5hcg
9. Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC. Fostering implementation of health services research findings into practice: A consolidated framework for advancing implementation science. Implement Sci [Internet]. 2009 Dec 7 [cited 2021 Jan 14];4(1). Available from: http://implementationscience.biomedcentral.com/articles/10.1186/1748-5908-4-50
10. Deslauriers J-P, Mainville S. Recherche qualitative: guide pratique. Can J Educ / Rev Can l’éducation [Internet]. 1992 [cited 2021 Jan 14];17(4):466. Available from: https://eduq.info/xmlui/handle/11515/6258
11. Minsalud. Acta No 01 de 2019. Sesion Ordinaria. 28, 29, 30 y 31 de Enero de 2019 In: Comision Revisora. Sala Especializada de Moleculas Nuevas NIyMB. 2019.
12. Sevelius JM, Deutsch MB, Grant R, JM Sevelius, MB Deutsch RG. Pre-Exposure Prophylaxis: A Narrative Review of Provider Behavior and Interventions to Increase PrEP Implementation in Primary Care. International AIDS Society; Oct 18, 2016 p. 21105.
13. Marcus JL, Volk JE, Pinder J, Liu AY, Bacon O, Hare CB, et al. Successful Implementation of HIV Preexposure Prophylaxis: Lessons Learned From Three Clinical Settings. Curr HIV/AIDS Rep [Internet]. 2016 Apr 1 [cited 2021 Jan 14];13(2):116–24. Available from: https://www.researchgate.net/publication/295687807
14. Organización Mundial de la Salud (OMS). Herramienta de la OMS para la Implementación de la Profilaxis Previa a la Infección por el VIH. OMS [Internet]. 2017 [cited 2021 Jan 25]; Available from: https://www.paho.org/es/documentos/herramienta-oms-para-implementacion-profilaxis-previa-exposicion-al-vih
15. Vanhamel J, Rotsaert A, Reyniers T, Nöstlinger C, Laga M, Van Landeghem E, et al. The current landscape of pre-exposure prophylaxis service delivery models for HIV prevention: A scoping review Pre-exposure prophylaxis (PrEP) for HIV prevention among men who have sex with men (MSM): A scoping review on PrEP service delivery and programm. BMC Health Serv Res [Internet]. 2020 Jul 31 [cited 2020 Dec 1];20(1). Available from: /pmc/articles/PMC7395423/?report=abstract
16. Sharma M, Chris A, Chan A, Knox DC, Wilton J, McEwen O, et al. Decentralizing the delivery of HIV pre-exposure prophylaxis (PrEP) through family physicians and sexual health clinic nurses: A dissemination and implementation study protocol. BMC Health Serv Res [Internet]. 2018 Jul 3 [cited 2021 Jan 25];18(1):513. Available from: https://bmchealthservres.biomedcentral.com/articles/10.1186/s12913-018-3324-2
17. Luz PM, Veloso VG, Grinsztejn B. The HIV epidemic in Latin America: Accomplishments and challenges on treatment and prevention [Internet]. Vol. 14, Current Opinion in HIV and AIDS. Lippincott Williams and Wilkins; 2019 [cited 2021 Jan 25]. p. 366–73. Available from: /pmc/articles/PMC6688714/?report=abstract
18. Schmidt H-M. Ending HIV and Australia’s success story in PrEP implementation.
19. Zablotska IB, Selvey C, Guy R, Price K, Holden J, Schmidt HM, et al. Expanded HIV pre-exposure prophylaxis (PrEP) implementation in communities in New South Wales, Australia (EPIC-NSW): Design of an open label, single arm implementation trial. BMC Public Health. 2018 Feb 2;18(1):210.
20. Turner L, Roepke A, Wardell E, Teitelman AM. Do You PrEP? A Review of Primary Care Provider Knowledge of PrEP and Attitudes on Prescribing PrEP. J Assoc Nurses AIDS Care [Internet]. 2018 Jan 1 [cited 2021 Jan 25];29(1):83–92. Available from: /pmc/articles/PMC7653672/?report=abstract
21. Blackstock OJ, Moore BA, Berkenblit G V., Calabrese SK, Cunningham CO, Fiellin DA, et al. A Cross-Sectional Online Survey of HIV Pre-Exposure Prophylaxis Adoption Among Primary Care Physicians. J Gen Intern Med [Internet]. 2017 Jan 1 [cited 2021 Jan 25];32(1):62–70. Available from: https://link.springer.com/article/10.1007/s11606-016-3903-z
22. Carter MR, Aaron E, Nassau T, Brady KA. Knowledge, Attitudes, and PrEP Prescribing Practices of Health Care Providers in Philadelphia, PA. J Prim Care Community Heal [Internet]. 2019 Jan 3 [cited 2021 Jan 25];10:215013271987852. Available from: http://journals.sagepub.com/doi/10.1177/2150132719878526
23. Nelson LRE, McMahon JM, Leblanc NM, Braksmajer A, Crean HF, Smith K, et al. Advancing the case for nurse practitioner-based models to accelerate scale-up of HIV pre-exposure prophylaxis. J Clin Nurs [Internet]. 2019 Jan 11 [cited 2021 Jan 25];28(1–2):351–61. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1111/jocn.14675
24. OʼByrne P, MacPherson P, Orser L, Jacob JD, Holmes D. PrEP-RN: Clinical Considerations and Protocols for Nurse-Led PrEP. J Assoc Nurses AIDS Care [Internet]. 2019 May 1 [cited 2021 Jan 14];30(3):301–11. Available from: /pmc/articles/PMC6551248/?report=abstract
25. Society EAC. Guía Clínica Versión 10.0 [Internet]. 2019 [cited 2021 Jan 25]. Available from: http://www.eacsociety.org
26. AMMI Canada position statement on the diagnosis and treatment of people with persistent symptoms that have been attributed to lyme disease. J Assoc Med Microbiol Infect Dis Canada [Internet]. 2019 [cited 2021 Jan 25];4(2):43–6. Available from: https://www.idsociety.org/public-health/lyme-disease/lyme-disease/chronic-lyme-
Cómo citar
Arrivillaga, M., Gómez, S. A., Mueses , H. F. ., Alvarado, B. ., Martínez Buitrago, E., Camargo-Plazas, P., Hurtado, L. R., Bolívar, M. C., Galindo, X., Torres, J. ., & Cajas-Martínez, J. L. . (2022). Facilitadores y recomendaciones de proveedores de salud para la implementación de la Profilaxis Pre-Exposición en clínicas de VIH en Colombia. “Estudio PPrE-Colombia”. Gerencia Y Políticas De Salud, 21. https://doi.org/10.11144/Javeriana.rgps21.frps
Sección
Artículos